119 related articles for article (PubMed ID: 21145162)
21. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.
Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H
J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994
[TBL] [Abstract][Full Text] [Related]
22. Aspirin resistance in secondary stroke prevention.
Berrouschot J; Schwetlick B; von Twickel G; Fischer C; Uhlemann H; Siegemund T; Siegemund A; Roessler A
Acta Neurol Scand; 2006 Jan; 113(1):31-5. PubMed ID: 16367896
[TBL] [Abstract][Full Text] [Related]
23. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
24. I've read that some people are aspirin resistant and do not benefit from the daily use of aspirin to prevent a heart attack or stroke. Should I be tested for aspirin resistance?
Johns Hopkins Med Lett Health After 50; 2010 Sep; 22(7):8. PubMed ID: 20848754
[No Abstract] [Full Text] [Related]
25. Statin and Aspirin Pretreatment Are Associated with Lower Neurological Deterioration and Platelet Activity in Patients with Acute Ischemic Stroke.
Yi X; Han Z; Wang C; Zhou Q; Lin J
J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):352-359. PubMed ID: 27793535
[TBL] [Abstract][Full Text] [Related]
26. Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
Smout J; Cleanthis M; Stansby G
Thromb Haemost; 2008 Jan; 99(1):239. PubMed ID: 18217162
[No Abstract] [Full Text] [Related]
27. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
Sztriha LK; Vécsei L
Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelets and stroke outcomes: state of the science.
Meyer D
Crit Care Nurs Clin North Am; 2009 Dec; 21(4):517-28. PubMed ID: 19951767
[TBL] [Abstract][Full Text] [Related]
29. Platelet aspirin resistance in ED patients with suspected acute coronary syndrome.
Glauser J; Emerman CL; Bhatt DL; Peacock WF
Am J Emerg Med; 2010 May; 28(4):440-4. PubMed ID: 20466222
[TBL] [Abstract][Full Text] [Related]
30. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
Park MK; Smith PC; Wanserski G; Neher JO
Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
[No Abstract] [Full Text] [Related]
31. Prevalence of aspirin resistance in stroke patients in Phramongkutklao Hospital.
Nidhinandana S; Changchit S
J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S51-4. PubMed ID: 21280515
[TBL] [Abstract][Full Text] [Related]
32. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
Griffin G
Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
[No Abstract] [Full Text] [Related]
33. Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients.
Sztriha LK; Sas K; Seres E; Boda K; Lenti L; Csifcsak G; Kovacs N; Vecsei L
Acta Neurol Scand; 2008 Apr; 117(4):250-4. PubMed ID: 17961197
[TBL] [Abstract][Full Text] [Related]
34. Aspirin resistance in cerebrovascular patients.
Feher A; Pusch G; Harang G; Gasztonyi B; Papp E; Werling D; Menyhart M; Komaromy H; Szapary L; Feher G
Int J Cardiol; 2011 Oct; 152(1):111-2. PubMed ID: 21794938
[No Abstract] [Full Text] [Related]
35. Clinical Implications of Changes in Individual Platelet Reactivity to Aspirin Over Time in Acute Ischemic Stroke.
Kim JT; Heo SH; Choi KH; Nam TS; Choi SM; Lee SH; Park MS; Kim BC; Kim MK; Saver JL; Cho KH
Stroke; 2015 Sep; 46(9):2534-40. PubMed ID: 26219647
[TBL] [Abstract][Full Text] [Related]
36. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB
Cerebrovasc Dis; 2010; 29(1):79-81. PubMed ID: 19907167
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment with aspirin and etiology of first-ever ischemic stroke in young and middle-aged patients.
Telman G; Kouperberg E; Sprecher E; Yarnitsky D
J Neurol Sci; 2009 Jun; 281(1-2):2-5. PubMed ID: 19351569
[TBL] [Abstract][Full Text] [Related]
38. Functional outcome and prevalence of recurrent ischemic events in patients with acute ischemic stroke due to aortic plaques.
Baumann CR; Baumgartner RW; von Büdingen HC; Rousson V; Siegel AM; Georgiadis D
Cerebrovasc Dis; 2007; 24(1):127-9. PubMed ID: 17565198
[No Abstract] [Full Text] [Related]
39. Aspirin resistant patients with recent ischemic stroke.
Castilla-Guerra L; Navas-Alcántara MS; Fernández-Moreno MC
Rev Clin Esp (Barc); 2014 Apr; 214(3):145-9. PubMed ID: 24211052
[TBL] [Abstract][Full Text] [Related]
40. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
